Neurokinin-1 receptor desensitization attenuates cutaneous active vasodilatation in humans

Journal of Physiology

Volumn 577, Issue 3, 2006, Pages 1043-1051

  Wong, Brett J ^a   Minson, Christopher T ^a  

^a UNIVERSITY OF OREGON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NEUROKININ 1 RECEPTOR; NITRIC OXIDE; NITROPRUSSIDE SODIUM; RINGER SOLUTION; SUBSTANCE P; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; BLOOD FLOWMETRY; CONTROLLED STUDY; DOSE RESPONSE; ERYTHROCYTE; FEMALE; FOREARM; HEAT STRESS; HEATING; HIGH TEMPERATURE PROCEDURES; HUMAN; HUMAN EXPERIMENT; LASER DOPPLER FLOWMETRY; MALE; MEAN ARTERIAL PRESSURE; MICRODIALYSIS; MOUTH TEMPERATURE; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SKIN BLOOD FLOW; SKIN BLOOD VESSEL; VASODILATATION; DESENSITIZATION; ENZYME INHIBITION; EXPERIMENTAL MODEL;

ADULT; BLOOD PRESSURE; ENZYME INHIBITORS; ERYTHROCYTES; FEMALE; HEAT; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; RECEPTORS, NEUROKININ-1; REGIONAL BLOOD FLOW; SKIN; STRESS; SUBSTANCE P; VASODILATION;

EID: 33845289034     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.112508     Document Type: Article

References (49)

1. Bennett LA, Johnson JM, Stephens DP, Saad AR & Kellogg DL (2003). Evidence for a role for vasoactive intestinal peptide in active vasodilatation in the cutaneous vasculature in humans. J Physiol 552, 223-232.
2. Binggeli C, Spieker LE, Corti R & Noll G (2003). Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: A monitoring test of endothelial dysfunction for clinical practice?J Am Coll Cardiol 42, 71-77.
3. Church MK, Suhad E-L & Caulfield JP (1991). Neuropeptide-induced secretion from human skin mast cells. Int Arch Allergy Appl Immunol 94, 310-318.
4. Fox RH & Hilton SM (1958). Bradykinin formation in human skin as a factor in heat vasodilatation. J Physiol 142, 219-232.
5. Grant RT & Holling HE (1938). Further observations on the vascular responses of the human limb to body warming: Evidence for sympathetic vasodilator nerves in the normal subject. Clin Sci 3, 273-285.
6. Grant RT & Pearson RSB (1938). The blood circulation in the human limb; observations on the differences between the proximal and the distal parts and remarks on the regulation of core body temperature. Clin Sci 3, 119-139.
7. Hokfelt T, Johnsson O, Ljungdahl A, Lundberg JM & Schultzberg M (1980 a). Peptidergic neurones. Nature 284, 515-521.
8. Hokfelt T, Lundberg JM, Schulzberg M, Johansson O, Ljungdahl A & Rehfeld J (1980 b). Coexistence of peptides and putative transmitters in neurons. Adv Biochem Psychopharmacol 22, 1-23.
9. Holzer P (1998). Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol 30, 5-11.
10. Huttunen M, Harvima IT, Ackermann L, Harvima RJ, Naukkarinen A & Horsmanheimo M (1996). Neuropeptide- and capsaicin-induced histamine release in skin monitored with the microdialysis technique. Acta Derm Venereol 76, 205-209.
11. Jansen I, Alafaci C, McCulloch J, Uddman R & Edvinsson L (1991). Tachykinins (substance P, neurokinin A, neuropeptide K, and neurokinin B) in the cerebral circulation: Vasomotor responses in vitro and in situ. J Cereb Blood Flow Metab 11, 567-575.
12. Kellogg DL, Crandall CG, Liu Y, Charkoudian N & Johnson JM (1998). Nitric oxide and cutaneous active vasodilatation during heat stress in humans. J Appl Physiol 85, 824-829.
13. Kellogg DL, Liu Y, Kosiba IF & O'Donnell D (1999). Role of nitric oxide in the vascular effects of local warming of the skin in humans. J Appl Physiol 86, 1185-1190.
14. Kellogg DL, Pergola PE, Piest KL, Kosiba WA, Crandall CG, Grossmann M & Johnson JM (1995). Cutaneous active vasodilatation in humans is mediated by cholinergic nerve cotransmission. Circ Res 77, 1222-1228.
15. Kellogg DL, Zhao JL, Friel C & Roman LJ (2003). Nitric oxide concentration increases in the cutaneous interstitial space during heat stress in humans. J Appl Physiol 94, 1971-1977.
16. Klede M, Clough G, Lischetzki G & Schmelz M (2003). The effect of the nitric oxide synthase inhibitor N-nitro-l-argining-methyl ester on neuropeptide-induced vasodilatation and protein extravasation in human skin. J Vasc Res 40, 105-114.
17. Kopp UC, Farley DM & Smith LA (1996). Renal sensory receptor activation causes prostaglandin-dependent release of substance P. Am J Physiol Regul Integr Comp Physiol 270, R720-R727.
18. Kopp UC & Smith LA (1993). Role of prostaglandins in renal sensory receptor activation by substance P and bradykinin. Am J Physiol Regul Integr Comp Physiol 265, R544-R551.
19. Krause JE, Hershey AD, Dykema PE & Takeda Y (1990). Molecular biological studies on the diversity of chemical signaling in tachykinin peptidergic neurons. Ann NY Acad Sci U S A 579, 254-272.
20. Mann PT, Southwell BR & Furness JB (1999). Internalisation of the neurokinin 1 receptor in rat myenteric neurons. Neuroscience 91, 353-362.
21. Marriott DR, Wilkin GP & Wood JN (1991). Substance P-induced release of prostaglandins from astrocytes: Regional specialisation and correlation with phosphoinositol metabolism. J Neurochem 56, 259-265.
22. McCord GR, Cracowski J-L & Minson CT (2006). Prostanoids contribute to cutaneous active vasodilation in humans. Am J Physiol Regul Integr Comp Physiol 291, R596-R602.
23. Minson CT, Berry LT & Joyner MJ (2001). Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J Appl Physiol 91, 1619-1626.
24. Minson CT, Holowatz LA, Wong BJ, Kenney WL & Wilkins BW (2002). Decreased nitric oxide- and axon reflex- mediated cutaneous vasodilatation with age during local heating. J Appl Physiol 93, 1644-1649.
25. Petersen LJ, Poulsen LK, Søndergaard J & Skov PS (1994). The use of cutaneous microdialysis to measure substance P-induced histamine release in human skin in vivo. J Allergy Clin Immunol 94, 773-783.
26. Quartara L & Maggi CA (1997). The tachykinin receptor. Part I: ligands and mechanisms of cellular activation. Neuropeptides 31, 537-563.
27. Ralevic V, Milner P, HudlickáO, Kristek F & Burnstock G (1990). Substance P is released from the endothelium of normal and capsaicin-treated rat hind-limb vasculature, in vivo, by increased flow. Circ Res 66, 1178-1183.
28. Regoli D, Boudon A & Fauchere JL (1994). Receptors and antagonists for substance P and related peptides. Pharmacol Rev 46, 551-599.
29. Roddie IC, Shepherd JT & Whelan RF (1957 a). The contribution of constrictor and dilator nerves to the skin vasodilatation during body heating. J Physiol 136, 489-497.
30. Roddie IC, Shepherd JT & Whelan RF (1957 b). The vasomotor nerve supply to the skin and muscle of human forearm. Clin Sci 16, 67-74.
31. Salvemini D (1997). Regulation of cyclooxygenase enzymes by nitric oxide. Cell Mol Life Sci 53, 576-582.
32. Salvemini D, Misko TP, Masferer JL, Seibert K, Currie MG & Needlman P (1993). Nitric oxide activates cyclooxygenase enzymes. Pharmacology 90, 7240-7244.
33. Salvemini D, Settle SL, Masferer JL, Seibert K, Currie MG & Needlman P (1995). Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br J Pharmacol 114, 1171-1178.
34. Savage MV, Brengelmann GL, Buchan AMJ & Freund PR (1990). Cystic fibrosis, vasoactive intestinal polypeptide, active cutaneous vasodilation. J Appl Physiol 69, 2149-2154.
35. Shastry S, Dietz NM, Halliwill JR, Reed AS & Joyner MJ (1998). Effects of nitric oxide synthase inhibition on cutaneous vasodilatation during body heating in humans. J Appl Physiol 85, 830-834.
36. Shastry S, Minson CT, Wilson SA, Dietz NM & Joyner MJ (2000). Effects of atropine and l -NAME on cutaneous blood flow during body heating in humans. J Appl Physiol 88, 467-472.
37. Shibasaki M, Wilson TE, Cui J & Crandall CG (2002). Acetylcholine release from cholinergic nerves contributes to cutaneous vasodilatation during heat stress. J Appl Physiol 93, 1947-1952.
38. Wallengren J (1997). Vasoactive peptides in the skin. J Investig Dermatol Symp Proc 2, 49-55.
39. Wallengren J, Ekman R & Sundler F (1987). Occurrence and distribution of neuropeptides in the human skin. Acta Derm Venereol 67, 185-192.
40. Weidner C, Klede M, Rukwied R, Lischetzki G, Neisius U, Skov PS, Petersen LJ & Schmelz M (2000). Acute effects of substance P and calcitonin gene-related peptide in human skin -a microdialysis study. J Invest Dermatol 115, 1015-1020.
41. Weihe E & Hartschuh W (1988). Multiple peptides in cutaneous nerves: regulators under physiological conditions and a pathogenetic role in skin disease? Semin Dermatol 7, 284-300.
42. Wilkins BW, Chung LH, Tublitz NJ, Wong BJ & Minson CT (2004). Mechanisms of vasoactive intestinal peptide (VIP)-mediated vasodilation in human skin. J Appl Physiol 97, 1291-1298.
43. Wilkins BW, Holowatz LA, Wong BJ & Minson CT (2003). Nitric oxide is not permissive for cutaneous active vasodilatation in humans. J Physiol 548, 963-969.
44. Wilkins BW, Wong BJ, Tublitz NJ, McCord GR & Minson CT (2005). The vasoactive intestinal peptide fragment VIP 10-28 and active vasodilation in human skin. J Appl Physiol 99, 2294-2301.
45. Wong BJ, Tublitz NJ & Minson CT (2005). Neurokinin-1 receptor desensitisation to consecutive microdialysis infusions of substance P in human skin. J Physiol 568, 1047-1056.
46. Wong BJ, Wilkins BW, Holowatz LA & Minson CT (2003). Nitric oxide synthase inhibition does not alter the reactive hyperemic response in the cutaneous circulation. J Appl Physiol 95, 504-510.
47. Wong BJ, Wilkins BW & Minson CT (2004). H 1 but not H 2 histamine receptor activation contributes to the rise in skin blood flow during whole body heating in humans. J Physiol 560, 941-948.
48. Yousufzai SYK, Akhtar RA & Abdel-Latif AA (1986). Effects of substance P on inositol triphosphate accumulation on contractile responses and on arachidonic acid release and prostaglandin biosynthesis in rabbit iris sphincter muscle. Exp Eye Res 43, 215-226.
49. Zhao JL, Pergola PE, Roman LJ & Kellogg DL Jr (2004). Bioactive nitric oxide concentration does not increase during reactive hyperemia in human skin. J Appl Physiol 96, 628-632.